maybe the environment / sentiment from big pharma has changed. or something has come into play for benitec that has enabled a change in strategy. i'm cool with flexible strategy if the cards are changing.
say they do land a modest deal for a pre clinical that had some useful upfront, if that deal were with a big pharma, then i think the market will value benitec not just on that deal alone, but also provide some re-evaluation based on it's other prospects. i don't want to speculate how much that re-evaulation could be, but bigger players taking a first look at benitec's other prospective therapy areas will be in for quite a surprise...
BLT Price at posting:
37.5¢ Sentiment: Buy Disclosure: Held